Login / Signup

Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy.

Wenjun JiangJiyuan ChenChunai GongYuanyuan WangYuan GaoYongfang Yuan
Published in: Journal of nanobiotechnology (2020)
The multifunctional nanocarrier constructed here could accomplish controlled Enz release and serve as an intravenous therapy platform for CRPC.
Keyphrases
  • drug delivery
  • oxide nanoparticles
  • prostate cancer
  • high dose
  • cancer therapy
  • emergency department
  • stem cells
  • room temperature
  • mesenchymal stem cells
  • electronic health record
  • single cell
  • walled carbon nanotubes